Fortitude Family Office’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24K | Sell |
54
-23
| -30% | -$10.2K | 0.01% | 346 |
|
|
2025
Q1 | $37.3K | Hold |
77
| – | – | 0.01% | 272 |
|
|
2024
Q4 | $31K | Buy |
77
+4
| +5% | +$1.61K | 0.01% | 353 |
|
|
2024
Q3 | $34K | Hold |
73
| – | – | 0.01% | 308 |
|
|
2024
Q2 | $34.2K | Hold |
73
| – | – | 0.02% | 223 |
|
|
2024
Q1 | $30.5K | Hold |
73
| – | – | 0.02% | 210 |
|
|
2023
Q4 | $29.7K | Buy |
+73
| New | +$29.7K | 0.02% | 232 |
|